Premium
Plasma concentrations of triazolam are increased by concomitant ingestion of grapefruit juice
Author(s) -
Hukkinen Sanna K.,
Varhe Anu,
Olkkola Klaus T.,
Neuvonen Pertti J.
Publication year - 1995
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1016/0009-9236(95)90188-4
Subject(s) - triazolam , grapefruit juice , chemistry , pharmacokinetics , pharmacology , crossover study , bioavailability , ingestion , medicine , benzodiazepine , placebo , biochemistry , receptor , alternative medicine , pathology
Background Grapefruit juice increases the bioavailability of several drugs known to be metabolized by CYP3A enzymes. Ketoconazole and itraconazole can increase the area under the concentration‐time curve [AUC(0‐∞)] of triazolam, a substrate of CYP3A, by more than twenty times. Methods In this randomized crossover study the effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of triazolam was investigated. Ten healthy young subjects received a single 0.25 mg dose of triazolam with either 250 ml grapefruit juice or water. Plasma concentrations and effects of triazolam were measured up to 17 hours. Results Grapefruit juice increased the AUC(0‐∞) of triazolam in each subject and the peak concentration in nine of the 10 subjects. The mean AUC(0‐∞) of triazolam was increased 1.5‐fold ( p < 0.001) and the peak concentration was increased 1.3‐fold ( p < 0.05) by grapefruit juice. Grapefruit juice postponed the peak time of triazolam from 1.6 hours to 2.5 hours ( p < 0.05). Grapefruit juice increased the effects of triazolam slightly; drowsiness was significantly ( p < 0.05) enhanced. Conclusions Grapefruit juice can increase the plasma concentrations and effects of oral triazolam. Clinical Pharmacology & Therapeutics (1995) 58 , 127–131; doi: